VELscope

The overall 5-year survival rate for oral cancer is 52%, but when discovered early, it increases to 80% - 90%

With the VELscope system we are equiped to detect oral cancer and pre-malignant lesions in the earliest stages possible. The VELscope™ System is a revolutionary hand-held device that provides us with an easy-to-use adjunctive mucosal examination system for the early detection of abnormal tissue. In fact, the VELscope™ System is the only adjunctive device cleared by the FDA and Health Canada to help discover oral mucosal lesions that might not be apparent or visible to the naked eye. We are proud to offer this technology to our patients and we feel confident that with it, we are doing everything possible to prevent the progression of oral cancer and save lives.